Local News: Old Mystic, CT 

 | 

Sign Up

 | 

Sign In

Advertisment

Foradil, Formoterol

Foradil, Formoterol Wire

Comprehensive News Feed for Foradil, Formoterol (generic).

Results 1 - 20 of 37 in Foradil, Formoterol (generic)

  1. Pearl Therapeutics Announces Positive Results from Phase 2a Trial of...Read the original story

    15 hrs ago | Drugs.com

    Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 2a dose-ranging study of PT001, the company's glycopyrrolate hydrofluoroalkane metered dose inhaler formulation.

    Comment?

    Related Topix: Healthcare Law, Law, Medicine, Robinul, Glycopyrrolate (generic), Medication, Copd, Health, Chronic Obstructive Pulmonary Disease, Food and Drug Administration

  2. Pearl Therapeutics Announces Positive Results From Phase 2a Trial of...Read the original story

    16 hrs ago | Drugs.com

    Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from its first clinical trial in patients with chronic obstructive pulmonary disease .

    Comment?

    Related Topix: Copd, Medicine, Health, Chronic Obstructive Pulmonary Disease, Asthma

  3. Pearl Therapeutics Announces Positive Results From Phase 2a...Read the original story

    Tuesday | Pharmaceutical Online

    Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from its first clinical trial in patients with chronic obstructive pulmonary disease .

    Comment?

    Related Topix: Copd, Medicine, Health, Chronic Obstructive Pulmonary Disease, Asthma

  4. Asthma medications and youRead the original story

    Tuesday | C-Health

    Asthma medications can fall into three general categories: relievers, controllers, and combination medications.

    Comment?

    Related Topix: Medicine, Health, Asthma

  5. Defective macrophage phagocytosis of bacteria in COPD.

    Saturday Jan 2 | CiteULike

    HEIRS Immunology and Autoimmune Diseases's tags for this article Abstract Exacerbations of chronic obstructive pulmonary disease are an increasing cause of hospitalizations and are associated with accelerated progression of airflow obstruction.

    Comment?

    Related Topix: Copd, Medicine, Health, Chronic Obstructive Pulmonary Disease, Immunology, Biology, Science

  6. Icon_question

    Friday Dec 25 | Heart Info

    Heart Disease Home > Questions > Sever pain left side just above the rib cage bottom and a little toward the front.

    Comment?

    Related Topix: Copd, Medicine, Health, Medication, Arthritis

  7. WADA list of prohibited substances 2010Read the original story

    Tuesday Dec 22 | Uefa.com

    The World Anti-Doping Agency has issued a new list of prohibited substances for 2010 and a new International Standards for Therapeutic Use Exemption , which will come into effect on 1 January 2010.

    Comment?

    Related Topix: Medicine, Asthma, Health

  8. SkyePharma: flutiform Phase III study completeRead the original story

    Nov 2, 2009 | Market Watch

    SkyePharma Plc, /quotes/comstock/11i!skyef /quotes/comstock/23s!e:skp the London producer of pharmaceuticals using proprietary drug-delivery technologies, said that a partner, Mundipharma International Corp., completed the final Phase III study of flutiform, which is being developed to treat asthma.

    Comment?

    Related Topix: Medicine, Health, Asthma, Medication, Fluticasone (generic), Flovent

  9. Flutiform EU Clinical Trial Successfully Completed

    Nov 2, 2009 | Earth Times

    FOR IMMEDIATE RELEASE SkyePharma Announces Successful Completion of FlutiformTM EU Clinical Trial Programme LONDON, UK, 2 November, 2009 - SkyePharma PLC today announces that its development and marketing partner Mundipharma International Corporation Limited has successfully completed the final Phase III clinical study for the European development ...

    Comment?

    Related Topix: SkyePharma, Biotech, Marketing, Medicine, Asthma, Health, Medication, Fluticasone (generic), Flovent

  10. Breathing EasierRead the original story

    Sep 26, 2005 | Advance For Physical Therapists

    Chronic obstructive pulmonary disease is a leading cause of death and disability in the United States.

    Comment?

    Related Topix: Copd, Medicine, Health, Chronic Obstructive Pulmonary Disease

  11. Inhaled Steroids: More Harm Than Good in COPD?Read the original story

    Oct 14, 2009 | MedlinePlus

    In people who suffer from COPD, a progressive lung disease that makes it hard to breathe, adding an inhaled steroid to a so-called "long-acting beta-2 agonist" may do more harm than good, new research hints.

    Comment?

    Related Topix: Medicine, Isoetharine (generic), Bronkosol, Medication, Montevideo, Uruguay, Uruguay, World News

  12. Triple Therapy Beneficial in Chronic Pulmonary DiseaseRead the original story w/Photo

    Oct 13, 2009 | Mental Help Net

    In patients with chronic obstructive pulmonary disease , triple therapy with budesonide/formoterol added to tiotropium significantly improves lung function and reduces severe exacerbations compared to monotherapy with tiotropium, according to a study published in the Oct.

    Comment?

    Related Topix: Medicine, Chronic Obstructive Pulmonary Disease, Health, Copd, Medication

  13. Inhaled steroids: more harm than good in COPD?Read the original story

    Oct 13, 2009 | Reuters

    In people who suffer from COPD, a progressive lung disease that makes it hard to breathe, adding an inhaled steroid to a so-called "long-acting beta-2 agonist" may do more harm than good, new research hints.

    Comment?

    Related Topix: Medicine, Isoetharine (generic), Bronkosol, Medication, Montevideo, Uruguay, Uruguay, World News, Health

  14. Triple Therapy Halves Exacerbations In Moderate-to-Severe COPDRead the original story

    Oct 8, 2009 | Medical News Today

    Main Category: COPD Also Included In: Respiratory / Asthma Article Date: 08 Oct 2009 - 19:00 PDT Patients with moderate to severe chronic obstructive pulmonary disease can benefit from triple therapy that includes a long-acting I2-agonist , an inhaled corticosteroid and an anti-muscarinic agent, according to researchers in Germany.

    Comment?

    Related Topix: Copd, Medicine, Health, Asthma, Chronic Obstructive Pulmonary Disease, Medication, Pulmicort, Budesonide (generic)

  15. Triple Therapy Halves Exacerbations In Moderate-to-Severe COPDRead the original story

    Oct 8, 2009 | MediLexicon

    Patients with moderate to severe chronic obstructive pulmonary disease can benefit from triple therapy that includes a long-acting I2-agonist , an inhaled corticosteroid and an anti-muscarinic agent, according to researchers in Germany.

    Comment?

    Related Topix: Copd, Medicine, Health, Chronic Obstructive Pulmonary Disease, Medication

  16. Triple Therapy Halves Exacerbations In Moderate-To-Severe COPDRead the original story

    Oct 8, 2009 | RedOrbit

    Patients with moderate to severe chronic obstructive pulmonary disease can benefit from triple therapy that includes a long-acting I2-agonist , an inhaled corticosteroid and an anti-muscarinic agent, according to researchers in Germany.

    Comment?

    Related Topix: Copd, Medicine, Health, Chronic Obstructive Pulmonary Disease, Medication

  17. Kylie is Bowled over by US tourRead the original story w/Photo

    Oct 5, 2009 | Daily Express

    COUGHING violently and struggling for breath, Julie Underwood was finally forced to admit defeat.

    Comment?

  18. Developing robust formoterol-containing suspension pMDIs with enhanced shelf lives

    Sep 30, 2009 | Pharmaceutical Technology

    Formoterol is increasingly viewed as the long-acting I22-agonist of choice by pharmaceutical companies wishing to participate in the dynamic inhaled corticosteroid plus long-acting I22-agonist combination therapy segment of the asthma and chronic obstructive pulmonary disease market.

    Comment?

    Related Topix: Medicine, Medication, Asthma, Health, Chronic Obstructive Pulmonary Disease, Copd, Advair Diskus, Fluticasone/Salmeterol (generic), Marketing

  19. Symbicort(R) Turbuhaler(R) SMART Improves Asthma Symptom Control And...

    Sep 15, 2009 | MediLexicon

    European Respiratory Society Congress 2009, Vienna, Austria, 15 September 2009: Symbicort Turbuhaler Maintenance and Reliever Therapy provides effective symptom control and reduces the risk of severe exacerbations in symptomatic asthma patients on inhaled corticosteroids or combination therapy of ICS and long-acting beta agonists over six months ...

    Comment?

    Related Topix: Medicine, Asthma, Health, Pulmicort, Budesonide (generic), Medication, Niederosterreich, Austria, World News, Austria, Vienna, Austria, France, Ile-Del-France, France, Paris, France

  20. SkyePharma Inc. Says More Tests Needed for Asthma DrugRead the original story

    Sep 1, 2009 | BioSpace

    As previously announced, in June 2009 the FDA gave preliminary notice of some potential review issues which it had identified in its preliminary evaluation of the NDA, which had been accepted for substantive review.

    Comment?

    Related Topix: SkyePharma, Biotech, Medicine, Healthcare Industry, Asthma, Health, Food and Drug Administration, Medication, Fluticasone (generic), Flovent